DBV Technologies establishes $150M ATM equity program via Citizens JMP; up to 50% dilution

DBV Technologies S.A.

ATM program allows sale of up to $150M in ADSs (each representing 5 ordinary shares) on Nasdaq through Citizens JMP.
Proceeds to fund BLA, potential launch of VIASKIN Peanut patch in toddlers aged 1-3, and pipeline development.
Maximum potential dilution of approximately 50% based on shareholder authorization of 136,948,870 ordinary shares.
Prior ATM program dated May 2, 2022 terminated; new program similar terms with 3% commission to agent.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.